CollPlant Biotechnologies Ltd. (CLGN)
NASDAQ: CLGN · Real-Time Price · USD
2.280
+0.120 (5.56%)
Nov 3, 2025, 4:00 PM EST - Market closed
CollPlant Biotechnologies Market Cap
CollPlant Biotechnologies has a market cap or net worth of $28.99 million as of November 3, 2025. Its market cap has decreased by -43.25% in one year.
Market Cap
28.99M
Enterprise Value
20.59M
1-Year Change
-43.25%
Ranking
Category
Stock Price
$2.28
Market Cap Chart
Since May 14, 2015, CollPlant Biotechnologies's market cap has decreased from $29.72M to $28.99M, a decrease of -2.43%. That is a compound annual growth rate of -0.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2025 | 28.99M | -29.69% |
| Dec 31, 2024 | 41.24M | -43.65% |
| Dec 29, 2023 | 73.18M | -21.52% |
| Dec 30, 2022 | 93.25M | -46.69% |
| Dec 31, 2021 | 174.91M | 147.09% |
| Dec 31, 2020 | 70.79M | 129.10% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 22, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 772.59B |
| Johnson & Johnson | 455.04B |
| AbbVie | 385.18B |
| UnitedHealth Group | 309.40B |
| AstraZeneca | 253.98B |
| Novartis AG | 237.13B |
| Novo Nordisk | 216.87B |
| Abbott Laboratories | 214.96B |